FLGT Q4 2020 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$458M

Q4 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$295M+3417.1% YoY

Gross Profit

$243M82.4% margin

Operating Income

$226M76.6% margin

Net Income

$166M56.4% margin

EPS (Diluted)

$6.16

QoQ Revenue Growth

+190.0%

Cash Flow

Operating Cash Flow

$134M

Free Cash Flow

$110M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$700M

Total Liabilities

$131M

Stockholders' Equity

$569M

Cash & Equivalents

$87M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$295M	$8M	+3417.1%
Gross Profit	$243M	$5M	+5016.9%
Operating Income	$226M	-$409,000	+55334.5%
Net Income	$166M	-$296,000	+56284.8%

Geographic Segments

UNITED STATES

$293M99%

Other Countries

$1M0%

CANADA

$401,0000%